Apellis Pharmaceuticals, Inc.APLSNASDAQ
Loading
PB Ratio: Discounted ValuationCompressed
Percentile Rank25
3Y CAGR-35.8%
5Y CAGR-16.5%
Year-over-Year Change
Price-to-book ratio
3Y CAGR
-35.8%/yr
vs +64.1%/yr prior
5Y CAGR
-16.5%/yr
Recent deceleration
Acceleration
-99.9pp
Decelerating
Percentile
P25
Within normal range
vs 5Y Ago
0.4x
Contraction
Streak
2 yr
Consecutive declineCompressed
| Period | Value | YoY Change |
|---|---|---|
| 2025 | 8.55 | -50.6% |
| 2024 | 17.30 | -52.6% |
| 2023 | 36.52 | +13.1% |
| 2022 | 32.30 | +60.8% |
| 2021 | 20.09 | -4.4% |
| 2020 | 21.02 | -62.2% |
| 2019 | 55.67 | +1148.9% |
| 2018 | 4.46 | -10.6% |
| 2017 | 4.99 | -53.3% |
| 2016 | 10.67 | - |